Doctor Feriel Azibani
University of Cape Town, Cape Town (South Africa)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Different outcome and fibrosis marker profiles suggest different pathomechanisms for peripartum cardiomyopathy in German and South African patients
Event: Heart Failure 2018
Topic: Pathophysiology and Mechanisms
Session: Acute Heart Failure – Pathophysiology and Mechanisms
Targeted interventions reducing late maternal death due to heart failure
Event: Heart Failure 2018
Topic: Treatment
Session: Acute Heart Failure– Treatment
Circulating growth-differentiation factor 15 in peripartum cardiomyopathy
Event: ESC Congress 2016
Topic: Pathophysiology and diagnosis
Session: Heart failure/Left ventricular function
Galectin 3 plasma levels at baseline correlate with poor clinical outcome in patients with peripartum cardiomyopathy
Event: HEART FAILURE 2016
Topic: Prognosis (using biomarkers)
Session: Basic Science: Biomarkers
ESC 365 is supported by
